Experimental FT-IR and UV–Vis spectroscopic studies and molecular docking analysis of anti-cancer drugs Exemestane and Pazopanib

•The world health organization (WHO) ranks cancer as the world's third most deadly disease.•The experimental FT-IR, UV–Vis Spectra have been analyzed and assigned functional groups.•The recombinant human cytochrome p450 aromatase binding protein was used in exemestane molecular docking studies.•The molecular docking studies of pazopanib was executed with tyrosine-protein kinase ABL1.•Molecular docking investigations identified hydrogen and other bonds between the atomic locations of the cancer medications and the binding proteins.